INTEGRA LIFESCIENCES HOLDINGS CORP Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount of $2.90 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Notes › Income Taxes
us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount · last filed 2026-05-05
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2026-03-31 was $2.90M, a 38.10% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2025-03-31 was $2.10M.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2022-06-30 was -$4.80M.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2022-03-31 was -$800.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2023 was -$5.80M.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2022 was -$5.10M.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2018 was -$1.10M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 6 month as first filed | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 9 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $2.90M 10-Q · filed 2026-05-05 | ||||
| 2025-03-31 | $2.10M 10-Q · filed 2026-05-05 | ||||
| 2024-09-30 | $1.90M 10-Q · filed 2024-11-04 | ||||
| 2024-06-30 | $1.70M 10-Q · filed 2024-07-29 | ||||
| 2023-12-31 | -$5.80M 10-K · filed 2026-02-26 | ||||
| 2023-06-30 | $300.00K 10-Q · filed 2024-07-29 | -$5.70M 10-Q · filed 2023-07-27 | |||
| 2022-12-31 | -$5.10M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | -$5.50M 10-Q · filed 2023-10-25 | ||||
| 2022-06-30 | -$4.80M 10-Q · filed 2022-07-27 | -$5.70M 10-Q · filed 2022-07-27 | |||
| 2022-03-31 | -$800.00K 10-Q · filed 2022-04-27 | ||||
| 2019-03-31 | -$700.00K 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | -$1.10M 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |